These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Crystal structure of the human angiotensin-converting enzyme-lisinopril complex. Natesh R; Schwager SL; Sturrock ED; Acharya KR Nature; 2003 Jan; 421(6922):551-4. PubMed ID: 12540854 [TBL] [Abstract][Full Text] [Related]
3. Simulated interactions between angiotensin-converting enzyme and substrate gonadotropin-releasing hormone: novel insights into domain selectivity. Papakyriakou A; Spyroulias GA; Sturrock ED; Manessi-Zoupa E; Cordopatis P Biochemistry; 2007 Jul; 46(30):8753-65. PubMed ID: 17605472 [TBL] [Abstract][Full Text] [Related]
4. Thermodynamic determination of the binding constants of angiotensin-converting enzyme inhibitors by a displacement method. Andújar-Sánchez M; Jara-Pérez V; Cámara-Artigas A FEBS Lett; 2007 Jul; 581(18):3449-54. PubMed ID: 17618628 [TBL] [Abstract][Full Text] [Related]
5. Crystal structure of the N domain of human somatic angiotensin I-converting enzyme provides a structural basis for domain-specific inhibitor design. Corradi HR; Schwager SL; Nchinda AT; Sturrock ED; Acharya KR J Mol Biol; 2006 Mar; 357(3):964-74. PubMed ID: 16476442 [TBL] [Abstract][Full Text] [Related]
6. Structural details on the binding of antihypertensive drugs captopril and enalaprilat to human testicular angiotensin I-converting enzyme. Natesh R; Schwager SL; Evans HR; Sturrock ED; Acharya KR Biochemistry; 2004 Jul; 43(27):8718-24. PubMed ID: 15236580 [TBL] [Abstract][Full Text] [Related]
7. Structure of angiotensin I-converting enzyme. Sturrock ED; Natesh R; van Rooyen JM; Acharya KR Cell Mol Life Sci; 2004 Nov; 61(21):2677-86. PubMed ID: 15549168 [TBL] [Abstract][Full Text] [Related]
8. Development of domain-selective angiotensin I-converting enzyme inhibitors. Redelinghuys P; Nchinda AT; Sturrock ED Ann N Y Acad Sci; 2005 Nov; 1056():160-75. PubMed ID: 16387685 [TBL] [Abstract][Full Text] [Related]
10. Structural determinants of RXPA380, a potent and highly selective inhibitor of the angiotensin-converting enzyme C-domain. Georgiadis D; Cuniasse P; Cotton J; Yiotakis A; Dive V Biochemistry; 2004 Jun; 43(25):8048-54. PubMed ID: 15209500 [TBL] [Abstract][Full Text] [Related]
11. Structure-function discrimination of the N- and C- catalytic domains of human angiotensin-converting enzyme: implications for Cl- activation and peptide hydrolysis mechanisms. Tzakos AG; Galanis AS; Spyroulias GA; Cordopatis P; Manessi-Zoupa E; Gerothanassis IP Protein Eng; 2003 Dec; 16(12):993-1003. PubMed ID: 14983080 [TBL] [Abstract][Full Text] [Related]
12. The structure of testis angiotensin-converting enzyme in complex with the C domain-specific inhibitor RXPA380. Corradi HR; Chitapi I; Sewell BT; Georgiadis D; Dive V; Sturrock ED; Acharya KR Biochemistry; 2007 May; 46(18):5473-8. PubMed ID: 17439247 [TBL] [Abstract][Full Text] [Related]
13. Studies on the molecular recognition between bioactive peptides and angiotensin-converting enzyme. Pina AS; Roque AC J Mol Recognit; 2009; 22(2):162-8. PubMed ID: 18816584 [TBL] [Abstract][Full Text] [Related]
14. A computational approach to the study of the binding mode of dual ACE/NEP inhibitors. Dimitropoulos N; Papakyriakou A; Dalkas GA; Sturrock ED; Spyroulias GA J Chem Inf Model; 2010 Mar; 50(3):388-96. PubMed ID: 20170101 [TBL] [Abstract][Full Text] [Related]
15. Structural features of angiotensin-I converting enzyme catalytic sites: conformational studies in solution, homology models and comparison with other zinc metallopeptidases. Spyroulias GA; Galanis AS; Pairas G; Manessi-Zoupa E; Cordopatis P Curr Top Med Chem; 2004; 4(4):403-29. PubMed ID: 14965309 [TBL] [Abstract][Full Text] [Related]
16. Synthesis and molecular modeling of a lisinopril-tryptophan analogue inhibitor of angiotensin I-converting enzyme. Nchinda AT; Chibale K; Redelinghuys P; Sturrock ED Bioorg Med Chem Lett; 2006 Sep; 16(17):4616-9. PubMed ID: 16784843 [TBL] [Abstract][Full Text] [Related]
17. Structure of human ACE gives new insights into inhibitor binding and design. Brew K Trends Pharmacol Sci; 2003 Aug; 24(8):391-4. PubMed ID: 12915047 [TBL] [Abstract][Full Text] [Related]
18. Homologous substitution of ACE C-domain regions with N-domain sequences: effect on processing, shedding, and catalytic properties. Woodman ZL; Schwager SL; Redelinghuys P; Chubb AJ; van der Merwe EL; Ehlers MR; Sturrock ED Biol Chem; 2006 Aug; 387(8):1043-51. PubMed ID: 16895474 [TBL] [Abstract][Full Text] [Related]
19. Positional-scanning combinatorial libraries of fluorescence resonance energy transfer peptides for defining substrate specificity of the angiotensin I-converting enzyme and development of selective C-domain substrates. Bersanetti PA; Andrade MC; Casarini DE; Juliano MA; Nchinda AT; Sturrock ED; Juliano L; Carmona AK Biochemistry; 2004 Dec; 43(50):15729-36. PubMed ID: 15595828 [TBL] [Abstract][Full Text] [Related]
20. Peptide inhibitors and the active site(s) of angiotensin converting enzyme. Riordan JF; Chen YN; Kleemann SG; Bünning P Biomed Biochim Acta; 1991; 50(4-6):809-14. PubMed ID: 1666286 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]